Condition: Idiopathic Nephrotic Syndrome · Sponsor: University Hospital, Limoges
Pediatric idiopathic nephrotic syndrome (INS) is a rare disease for which the optimal therapeutic strategy has not yet been defined. A network of clinicians treating complicated forms of this disease (grouped within the Société de Néphrologie Pédiatrique, SNP) exists, but to date there is no prospective cohort following up these patients that would facilitate the development of cohort-nested trials. This absence of structured follow up makes it difficult to set up prospective studies. The main objective is to create a prospective cohort of pediatric INS patients to collect cases treated in SNP centers, to study their epidemiological characteristics, and to provide a basis for comparison for future cohort-nested trials.
This description comes directly from the study's public registry record.
Vincent Guigonis, MD · +33 5 55 0563 58 · vincent.guigonis@unilim.fr
Claire Bahans, PhD · +33 5 55 05 63 58 · claire.bahans@chu-limoges.fr
Always discuss trial participation with your own doctor first.
| CH d'Agen | Agen, France | Recruiting |
| CHU d'Amiens | Amiens, France | Recruiting |
| CHU d'Auxerre | Auxerre, France | Recruiting |
| CH de la côte basque | Bayonne, France | Recruiting |
| CHU de Besançon | Besançon, France | Recruiting |
| CHU de Boredeaux | Bordeaux, France | Recruiting |
| CHU de Brest | Brest, France | Recruiting |
| HCL Lyon | Bron, France | Recruiting |
| CH de Chambéry | Chambéry, France | Recruiting |
| CHU de Clermont Ferrand | Clermont-Ferrand, France | Recruiting |
| CHU de Dijon | Dijon, France | Recruiting |
| CH du Val d'Ariège | Foix, France | Recruiting |
+ 36 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04207580